(secondQuint)Pharmacokinetic Study of Fentanyl 400 g Sublingual Spray, Actiq 400 g Transmucosally, and Fentanyl Citrate Injection 100 g Intravenously (iv).

 This was a Phase I, single-dose, open-label, randomized, 3-period, 3-treatment cross over study in which 21 healthy subjects received single doses of fentanyl 400 mu g sublingual spray, Actiq(R) 400 mu g transmucosally, and fentanyl citrate injection 100 mu g intravenously following a 10-hour overnight fast.

 There was a 7 day washout period between treatments.

.

 Pharmacokinetic Study of Fentanyl 400 g Sublingual Spray, Actiq 400 g Transmucosally, and Fentanyl Citrate Injection 100 g Intravenously (iv)@highlight

The objective of this study was to compare the rate of absorption and bioavailability of fentanyl 400 mu g sublingual spray, Actiq(R) 400 mu g transmucosally, and fentanyl citrate injection 100 mu g intravenously.

